A detailed history of Tejara Capital LTD transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 68,517 shares of OVID stock, worth $77,424. This represents 0.02% of its overall portfolio holdings.

Number of Shares
68,517
Previous 73,153 6.34%
Holding current value
$77,424
Previous $223 Million 76.38%
% of portfolio
0.02%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.7 - $3.34 $3,245 - $15,484
-4,636 Reduced 6.34%
68,517 $52.7 Million
Q4 2023

Feb 12, 2024

BUY
$2.98 - $3.78 $217,995 - $276,518
73,153 New
73,153 $236 Million
Q2 2023

Aug 11, 2023

SELL
$2.53 - $3.89 $15,685 - $24,118
-6,200 Reduced 5.22%
112,591 $369 Million
Q1 2023

May 12, 2023

BUY
$1.88 - $2.85 $21,244 - $32,205
11,300 Added 10.51%
118,791 $306 Million
Q4 2022

Feb 13, 2023

BUY
$1.43 - $1.89 $153,712 - $203,157
107,491 New
107,491 $200 Million

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $79.6M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.